✦ LIBER ✦

Gene Expression Profile Towards the Prediction of Patient Survival of Gastric Cancer

✍ Scribed by Zhen-yu Xu; Yong-qian Shu

Book ID: 116314185
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 37 KB
Volume: 63
Category: Article
ISSN: 0753-3322
DOI: 10.1016/j.biopha.2009.04.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene expression profile towards the pred

Gene expression profile towards the prediction of patient survival of gastric cancer

✍ Zhen-Yu Xu; Jia-Shun Chen; Yong-Qian Shu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Gene Expression Profile of Primary Gastr

Gene Expression Profile of Primary Gastric Cancer: Towards the Prediction of Lymph Node Status

✍ Alberto Marchet; Simone Mocellin; Claudio Belluco; Alessandro Ambrosi; Francesco 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 313 KB

Gene-expression profiles predict surviva

Gene-expression profiles predict survival of patients with lung adenocarcinoma

✍ Beer, David G.; Kardia, Sharon L.R.; Huang, Chiang-Ching; Giordano, Thomas J.; L 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 882 KB

Combined Expression of Metaplastic Bioma

Combined Expression of Metaplastic Biomarkers Predicts Survival of Gastric Cancer Patients

✍ Lee, Hyuk-Joon ;Suh, Yunsuhk ;Jung, Eun-Jung ;Kim, Min-A ;Nam, Ki Taek ;Yang, Ha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Prediction of disease-free survival in g

Prediction of disease-free survival in gastric cancer using gene expression data

✍ Boussioutas, Alex; Van Laar, Ryan; Desmond, Paul; Bowtell, David 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 482 KB

Prediction of recurrence in advanced gas

Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling

✍ Masaaki Motoori; Ichiro Takemasa; Masahiko Yano; Sakae Saito; Hiroshi Miyata; Sh 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 198 KB 👁 1 views

## Abstract The prognosis of patients with advanced gastric cancer remains unfavorable. Even after curative resection, 40% of patients with advanced gastric cancer die of recurrence. Conventional clinicopathlogic findings are sometimes inadequate for predicting recurrence in individuals. Hence, we